The ketogenic diet may target cancer’s metabolic vulnerability, particularly in glioma and other metabolically dysregulated cancers, by lowering glucose and insulin, reducing inflammation and oxidative stress, and enhancing tumor response to standard therapies (46). The gene discussed is INS; the disease is cancer.